GERON
Geron Corp. operates as a biopharmaceutical company which discovers and develops therapeutic products for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is a product candidate in clinical development.
GERON
Industry:
Biopharma Biotechnology Health Diagnostics Pharmaceutical
Founded:
1990-08-28
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.geron.com
Total Employee:
101+
Status:
Active
Contact:
6504737718
Total Funding:
361.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Apache Microsoft Exchange Online
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Aleksandra Rizo Executive Vice President, Chief Medical Officer @ Geron
Executive Vice President, Chief Medical Officer
2019-01-01
Melissa Kelly Behrs EVP, Business Development and Portfolio & Alliance Management @ Geron
EVP, Business Development and Portfolio & Alliance Management
2014-01-01
Olivia K. Bloom CFO, Treasurer & EVP @ Geron
CFO, Treasurer & EVP
2014-01-01
Karin Eastham Board of Directors @ Geron
Board of Directors
2009-01-01
Anil Kapur Executive Vice President, Corporate Strategy and Chief Commercial Officer @ Geron
Executive Vice President, Corporate Strategy and Chief Commercial Officer
Stephen Rosenfield EVP, General Counsel and Corporate Secretary @ Geron
EVP, General Counsel and Corporate Secretary
John A. Scarlett President, CEO & Director @ Geron
President, CEO & Director
2014-01-01
Edward Koval EVP & Chief Business Officer @ Geron
EVP & Chief Business Officer
2021-12-01
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Geron
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Geron
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Geron
Venrock
Venrock investment in Seed Round - Geron
Key Employee Changes
Official Site Inspections
http://www.geron.com Semrush global rank: 397.72 K Semrush visits lastest month: 140.19 K
- Host name: a545f4e6291a32fb6.awsglobalaccelerator.com
- IP address: 76.223.5.127
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Geron"
Our tireless pursuit - Geron
Geron (the “Company”) recognizes the value of each individual and is committed to providing equal employment and advancement opportunities. In accordance with applicable law, we …See details»
Geron Corporation - Investors & Media
Mar 11, 2025 Geron is a commercial-stage biopharmaceutical company with a first-in-class telomerase inhibitor that is approved in the United States for the treatment of certain adult …See details»
Geron
Scientific study of aging: The Gerontological Society of America (GSA) is a leading, forward-thinking interdisciplinary organization devoted to research, education, advocacy and practice …See details»
Geron Corporation - Wikipedia
Geron, based in Foster City, California, was founded by gerontologist Mary C. West and Michael D. West, now CEO of AgeX Therapeutics. They secured initial venture capital investments in the company from Kleiner Perkins Caufield & Byers and Venrock. The company was incorporated in 1990 and began doing business in 1992. John A. Scarlett was appointed CEO in 2011. The company's Scientific and Clinical Advisory Board has included Nobel laureates James WatsonSee details»
Contact us - Geron
Corporate Headquarters. 919 E. Hillsdale Blvd, Suite 250 Foster City, CA 94404 (650) 473-7700See details»
Geron - Crunchbase Company Profile & Funding
Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies. The company's Imetelstat, an investigational first-in-class telomerase inhibitor, harnesses Nobel Prize …See details»
Geron - The Org
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic …See details»
Geron: Contact Details, Revenue, Funding, Employees and …
Geron is a commercial-stage biopharmaceutical company focused on blood cancer treatment. Their FDA-approved telomerase inhibitor targets low-to-intermediate-risk myelodysplastic …See details»
Org Chart Geron - The Official Board
The organizational chart of Geron displays its 24 main executives including John Scarlett, Dawn Carter Bir, Michelle Robertson and Patrick Murphy. Toggle navigation The Official Board. …See details»
Geron Corporation - Investors & Media - Corporate Governance
Stockholders wishing to contact Geron’s Board of Directors, may do so by writing c/o Secretary, Geron Corporation, 919 E. Hillsdale, Suite 250, Foster City, CA 94404, or via email to …See details»
Our story continues to evolve - Geron
For more than 30 years, Geron has tirelessly dedicated itself to the pursuit of new therapies for patients with blood cancers ... Elizabeth H. Blackburn – Facts (nobelprize.org). Accessed …See details»
Geron Corporation Announces Departure of Chief Executive Officer
Mar 11, 2025 Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced …See details»
Geron Corporation (GERN) - Yahoo Finance Canada
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the …See details»
Our leadership team - Geron
Our leadership. With a seasoned leadership team with world-class expertise spanning research, clinical development, regulatory, manufacturing and commercial experience in hematologic …See details»
Login - Geron
Gerontological Society of America 1101 14th Street NW, Suite 1220 Washington, DC 20005 United StatesSee details»
Geron Corporation Announces Departure of Chief Executive Officer
Mar 11, 2025 FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course …See details»
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a …
2 days ago NEW YORK, March 25, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation ("Geron" or the "Company") …See details»
Geron Corporation - Geron Corporation Reports Third Quarter …
Nov 7, 2024 FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course …See details»
Faruqi & Faruqi Reminds Geron Investors of the Pending
1 day ago Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Geron To Contact Him Directly To …See details»
Our culture sets us apart - Geron
At Geron, our innovative and collaborative culture has been foundational to advancing our mission to change lives by changing the course of blood cancer. Our vision can only be accomplished …See details»